Share This Author
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
Survey shows that OTDs are fairly frequent in patients with SARS-CoV-2 infection and may precede the onset of full-blown clinical disease, which could explain the underlying pathogenetic mechanism of taste and olfactory disorders in SARS.
Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study.
Clinical features and outcomes of HIV patients with coronavirus disease 2019
47 patients referred to the authors' hospital between 21 February and 16 April 2020 with proven/probable COVID-19, 45 (96%) of whom fully recovered and two died, including two who died from SARS-CoV-2.
Body Habitus Changes and Metabolic Alterations in Protease Inhibitor‐Naive HIV‐1‐Infected Patients Treated With Two Nucleoside Reverse Transcriptase Inhibitors
- M. Galli, A. Ridolfo, M. Moroni
- Medicine, BiologyJournal of acquired immune deficiency syndromes
- 1 January 2002
Treatment with NRTIs may be responsible for the same morphologic alterations as those observed in patients treated with PIs, and altered triglyceride levels are also frequently observed.
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.
The observed body modifications are caused by a redistribution of body fat without fat loss that is apparently not associated with hyperlipidemia, altered glucose metabolism or other endocrinological disorders.
Darunavir does not prevent SARS-CoV-2 infection in HIV patients
Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men.
- A. Saracco, M. Musicco, R. Luzzati
- Medicine, BiologyJournal of Acquired Immune Deficiency Syndromes
- 1 May 1993
A cohort of 343 seronegative women, stable, monogamous partners of infected men whose only risk of acquiring HIV was sexual exposure to the infected partner, followed to study incidence and risk factors of heterosexually transmitted HIV infection.
Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19
47 patients referred to the authors' hospital between 21 February and 16 April 2020 with proven/probable COVID-19, 45 (96%) of whom fully recovered and 2 who died.
THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME BEFORE AND DURING THE ERA OF INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
- C. Gervasoni, A. Ridolfo, M. Galli
- Medicine, BiologyClinical infectious diseases : an official…
- 1 August 2002
The disappearance of TMA during the HAART era may be explained by the lower percentage of patients with long-lasting CD4+ T cell depletion, advanced AIDS, or cryptosporidiosis or who have undergone multiple courses of chemotherapy for treatment of cancer.